Loading…
Back To Schedule
Tuesday, June 29 • 9:00am - 10:00am
#205 SS: Spotlight Symposia: Three Paths to Success in a Post-COVID World

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Session
Level: Intermediate

- The status of market uptake for select CNS clinical trials by the pharma industry: rejuvenated interest and continued challenges ahead. - Continuously improved solutions are no longer a nice-to-have. - COVID implications on patient selection, study analytics, and placebo response reduction. - The future of CNS drug development.

Chair

WCG Clinical Services

Speakers
avatar for Bob Dagher

Bob Dagher

Chief Medical Officer, WCG MedAvante-ProPhase, United States
Dr. Bob Dagher is a seasoned executive leader with diverse biopharmaceutical roles in clinical development, medical affairs and commercial strategy. Most recently prior to joining WCG MA-PP, Dr. Dagher was the Chief Medical Officer of Cadent Therapeutics. Preceding that, he had occupied... Read More →
avatar for Mark Opler

Mark Opler

Chief Research Officer, WCG MedAvante-ProPhase, United States
Dr. Mark Opler is Chief Research Officer at WCG MedAvante-ProPhase Inc., managing and directing global research programs. Dr. Opler has served on the faculties of New York University Medical School and in the Department of Clinical Neuroscience at Columbia University’s College of... Read More →

Tuesday June 29, 2021 9:00am - 10:00am EDT
TBD Virtual Event Horsham, PA 19044
  23: Spotlight Symposia, Session